Literature DB >> 30499243

A Preview of Selected Articles.

Stuart P Atkinson1.   

Abstract

Year:  2018        PMID： 30499243      PMCID： PMC6265628          DOI： 10.1002/sctm.18-0241

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN： 2157-6564            Impact factor:   6.940


× No keyword cloud information.
  12 in total

1.  Pulsed focused ultrasound pretreatment improves mesenchymal stromal cell efficacy in preventing and rescuing established acute kidney injury in mice.

Authors:  Scott R Burks; Ben A Nguyen; Pamela A Tebebi; Saejeong J Kim; Michele N Bresler; Ali Ziadloo; Jonathan M Street; Peter S T Yuen; Robert A Star; Joseph A Frank
Journal:  Stem Cells       Date:  2015-04       Impact factor: 6.277

Review 2.  Mesenchymal stem cells: a new therapeutic tool for AKI.

Authors:  Florian E Tögel; Christof Westenfelder
Journal:  Nat Rev Nephrol       Date:  2010-03       Impact factor: 28.314

Review 3.  Acute kidney injury and chronic kidney disease as interconnected syndromes.

Authors:  Lakhmir S Chawla; Paul W Eggers; Robert A Star; Paul L Kimmel
Journal:  N Engl J Med       Date:  2014-07-03       Impact factor: 91.245

4.  In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability.

Authors:  Aboulghassem Shahdadfar; Katrine Frønsdal; Terje Haug; Finn P Reinholt; Jan E Brinchmann
Journal:  Stem Cells       Date:  2005-08-04       Impact factor: 6.277

5.  Prostaglandin E2 Indicates Therapeutic Efficacy of Mesenchymal Stem Cells in Experimental Traumatic Brain Injury.

Authors:  Daniel J Kota; Karthik S Prabhakara; Naama Toledano-Furman; Deepa Bhattarai; Qingzheng Chen; Bryan DiCarlo; Philippa Smith; Fabio Triolo; Pamela L Wenzel; Charles S Cox; Scott D Olson
Journal:  Stem Cells       Date:  2017-03-16       Impact factor: 6.277

Review 6.  Clinical trials in traumatic brain injury: past experience and current developments.

Authors:  Andrew I R Maas; Bob Roozenbeek; Geoffrey T Manley
Journal:  Neurotherapeutics       Date:  2010-01       Impact factor: 7.620

Review 7.  Mesenchymal stem cell treatment for chronic renal failure.

Authors:  Alfonso Eirin; Lilach O Lerman
Journal:  Stem Cell Res Ther       Date:  2014-07-04       Impact factor: 6.832

8.  Impact of the uremic milieu on the osteogenic potential of mesenchymal stem cells.

Authors:  Diana Lanza; Alessandra F Perna; Adriana Oliva; Raymond Vanholder; Anneleen Pletinck; Salvatore Guastafierro; Annarita Di Nunzio; Carmela Vigorito; Giovambattista Capasso; Vera Jankowski; Joachim Jankowski; Diego Ingrosso
Journal:  PLoS One       Date:  2015-01-30       Impact factor: 3.240

9.  Serum-Free Medium Enhances the Immunosuppressive and Antifibrotic Abilities of Mesenchymal Stem Cells Utilized in Experimental Renal Fibrosis.

Authors:  Ken Yoshida; Ayumu Nakashima; Shigehiro Doi; Toshinori Ueno; Tomoe Okubo; Ki-Ichiro Kawano; Masami Kanawa; Yukio Kato; Yukihito Higashi; Takao Masaki
Journal:  Stem Cells Transl Med       Date:  2018-09-30       Impact factor: 6.940

10.  Neurodevelopmental outcomes of extremely low-gestational-age neonates with low-grade periventricular-intraventricular hemorrhage.

Authors:  Allison H Payne; Susan R Hintz; Anna Maria Hibbs; Michele C Walsh; Betty R Vohr; Carla M Bann; Deanne E Wilson-Costello
Journal:  JAMA Pediatr       Date:  2013-05       Impact factor: 16.193
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.